Close this search box.
Close this search box.
Close this search box.

G2MC 5th International Conference

May 6 - May 8, 2020

Virtual Meeting


The G2MC Virtual Conference has concluded. A huge thanks to our sponsors, organizing partners, planning committee, speakers, and attendees for making this a successful event! Conference materials are posted below.

About the Event

G2MC held its 5th Global Genomic Medicine Conference as an abbreviated virtual meeting due to the global impact of the coronavirus pandemic. Leaders in Genomic Medicine across the globe tuned in to define collaborative projects and strategies for using genomic advances to improve clinical care globally. Session topics included:

  • Genomic Landscape in Latin America
  • Genomics of Common Disorders
  • Genomics of Rare Disorders
  • Solutions to Roadblocks

Many speakers also took the opportunity to share how their organizations and countries are using genomic methods to address the COVID-19 response. Read More.

The virtual conference was made possible by organizing partners The Golden Helix Foundation and Universidad del Desarrollo, and our virtual conference sponsors

Conference Highlights and Materials

Session Videos

Presentation Slides

  • Patient Participation and Advocacy
    In this presentation, Cecilia Rodriguez the importance of patient empowerment, patient engagement, and adopting an interactive approach to better engage patients in their healthcare.
  • Development of an Actionable NGS Cancer Panel in the Chilean Health Care System
    This presentation describes the ways in which genomic medicine is used in oncology biomarker detection and treatment. Dr. Marcelain specifically spoke on the use of TumorSec to help in identifying cancer in patients in Chile.
  • Latin American Hereditary Cancer Network
    This presentation describes Lynch Syndrome, a rare type of colorectal cancer, and its prevalence in Latin America. Dr. Dominguez-Valintin also describes research collaborations, relevant publications, insights from a worldwide database, educational programs, and funding available for managing colorectal cancer.
  • Education and Workforce
    In this presentation, Dr. Taucher outlines the importance of genomic medicine, and the need for better education and training of healthcare professionals on this topic. She concludes the presentation with recommendations for improving Chilean public health in regards to genomic medicine.
  • Chilean Response to COVID-19
    This presentation describes SARS-CoV-2 and its effects on the Chilean healthcare system. Dr. Araos explains the timeline and epidemiology of the disease, the steps the Chilean government took to control the disease, and the challenges for continued control.
  • The Brazilian Reference Genome Project
    In this presentation, Dr. Pereira describes the Brazilian Reference Genome Project, which is working closely with ELSA Brasil. She describes the current strategy in place for this project, on a short and log-term basis.

Session Videos

Presentation Slides

Session Videos

Presentation Slides

  • Return of results and scaling their model
    In this presentation Kelly East describes the training and considerations needed to enact a genome sequencing project in the southern US. This project utilized non-genetics healthcare providers to return results, which produced a more efficient work-flow and increased communication with patients.

  • The International Rare Diseases Research Consortium (IRDiRC)
    In this presentation, Dr. Reichardt discusses the IRDiRC, their goals, current task forces, scientific committee, and possible new directions.

  • Regional Rare Disease Diagnostic Programs
    This presentation describes the rare disease programs currently present in Latin America. Specifically, Dr. Poli discusses the DECIPHERD and Immunodeficiency cohorts and their approaches to, successes, and challenges in the rare disease space.

  • Genomic Workforce Development, Engagement and Education in New Zealand
    In this presentation, Dr. Thunders describes the Genomic medicine and Genetics workforce specifically in New Zealand. She also addresses the educational requirements for genomic medicine students, the barriers to genomic medicine, and proposed solutions to these issues.

  • Australian Genomics
    In this presentation, Professor Sinclair describes the purposes of the Australian Genomics Health Alliance and its approach to betting the Australian Health Care System through thier many programs, projects, and flagships. He also highlights the outcomes and impacts from these programs.

Session Videos

Presentation Slides

Session Videos

Presentation Slides

  • Education WG Breakout Report
    The Education working group co-chairs, Drs. Korf, Haspel, and Dissanayake, describe the next steps for the group. These steps inlcude analysis of the Education Needs Assessment survey and planning of a genomic medicine immersion course for the next face-to-face conference.

  • Evidence WG Breakout Report
    The Education working group co-chairs, Drs. Abramowicz and Al-Mulla describe the aims and scope of the working group, as well as the upcoming tasks and timeline for implementation.

  • Rare Disease FP Breakout Report
    The Rare Genetic Disorder co-chairs, Drs. Dissanayake and Shuldiner give a report on the overall implementation objectives of the group, a recap of the breakout discussion, and the next steps for the project.

  • Family Health History Breakout Report
    The Family Health History Flagship Project co-chair, Grant Wood, discussed the group’s breakout report. This included possible fudning sources, related organizations/initiatives, common Family Health History use cases, and the group’s overall goals.

Human genetics and genomics meetings going virtual: practical lessons learned from two international meetings in early 2020” published in Human Genomics. This article, co-authored by virtual conference organizing co-chair Gabriela Repetto, discusses lessons learned from moving two human genetics and genomics meetings quickly to an online format in early 2020 as a result of the coronavirus pandemic.

About G2MC

G2MC is a not-for-profit organization based in the United States that was established in 2016 with the goal of bringing together the global community to enable the implementation of genomic medicine to improve individual and population health. Since its formation, G2MC has held international conferences approximately every 18 months to bring together leaders and experts in the field of genomic medicine from across the globe to explore and discuss advances in genomic medicine and brainstorm solutions to roadblocks. As an outcome of the 2018 International Conference in Capetown, South Africa, G2MC re-defined its mission to focus on low-resource settings – areas where the implementation of genomic medicine in healthcare could intensely improve the lives and health of individuals and communities.